Category Archives: Events

Latest From Events

Promising vaccine companies set to take the stage at BIO Investor Forum

BIO Investor Forum

It is no secret that vaccines are a hot space in biotech right now, and the 13th Annual BIO Investor Forum will feature several companies working on promising vaccine R&D. The event, scheduled for October 7-8 in San Francisco, Calif., will feature 120 late-stage private and emerging public company presentations. Attendees at the BIO Investor Forum will hear from Immunovaccine, a clinical-stage vaccine development company focused on product candidates for cancer therapy, infectious disease and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Latin America Program Highlights

LatinAmerica_205x100_Thumbnail copy

BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, Brazil, and with this in mind BIO has announced the preliminary program as well as an initial list of presenting companies. Program topics include: Regional Biotech Development: Frameworks for Innovation Incentivizing Entrepreneurship and Investment in Latin America The Innovation Ecosystem in Brazil: From Biofuels to Biotherapeutics Tech Transfer: Industry and University Collaborations Regional Regulations for Biotherapeutics Clinical Trials: Addressing Challenges Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Buzz of BIO to recognize the most innovative companies at the 2014 BIO Investor Forum™

BIF-BuzzofBIO-116x76

Nominations are now open for the Buzz of BIO at the 2014 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage private companies hoping to make the valuable Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech CEOs Speak Out on JOBS Act Success

Biotech IPOs Infographic

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and ingenuity by removing bureaucratic hurdles and red tape to speed cures and medical breakthroughs to patients. The JOBS Act reached a major milestone last week, with the 100th company going public under its provisions. On October 7th at the 13th Annual BIO Investor Forum, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Partnering Trends in Latin America

BIO-One-On-One

If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making and partnering growth in Brazil and the rest of Latin America provide good reason to put the “B” in front. Traditional partnerships (i.e. excluding M&A and early venture funding) where a Latin American company served as the ‘seller’ or ‘out-licensor’ doubled per year from 2009/2010 to 2012. While there was a pullback in 2013, overall growth from 2009/2010 to 2013 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,